Diminished phosphodiesterase-8B potentiates biphasic insulin response to glucose

Endocrinology

Volumn 149, Issue 2, 2008, Pages 741-748

  Dov, Avital ^a   Abramovitch, Eva ^a   Warwar, Nasim ^a   Nesher, Rafael ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; PHOSPHODIESTERASE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IIIA; PHOSPHODIESTERASE IIIB; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IVB; PHOSPHODIESTERASE IVD; PHOSPHODIESTERASE VIIIB; PROTEINASE INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; GENE CONTROL; GENETIC VARIABILITY; INSULIN RELEASE; INSULIN RESPONSE; MALE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3',5'-CYCLIC-AMP PHOSPHODIESTERASES; ANIMALS; CELL LINE, TUMOR; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; INSULINOMA; MALE; PANCREATIC NEOPLASMS; RATS; RATS, WISTAR;

EID: 38549127858     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0968     Document Type: Article

References (47)

1. Deeney JT, Prentki M, Corkey BE 2000 Metabolic control of β-cell function. Semin Cell Dev Biol 11:267-275
2. Rutter GA 2001 Nutrient-secretion coupling in the pancreatic islet β-cell: recent advances. Mol Aspects Med 22:247-284
3. Furman B, Pyne N 2006 Modulation of cyclic nucleotides and cyclic nucleotide phosphodiesterases in pancreatic islet β-cells and intestinal L-cells as targets for treating diabetes mellitus. Curr Opin Investig Drugs 7:898-905
4. Furman B, Pyne N, Flatt P, O'Harte F 2004 Targeting β-cell cyclic 3′5′ adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A review. J Pharm Pharmacol 56:1477-1492
5. Grill V, Cerasi E 1973 Activation by glucose of adenyl cyclase in pancreatic islets of the rat. FEBS Lett 33:311-314
6. Grill V, Cerasi E 1974 Stimulation by D-glucose of cyclic adenosine 3′:5′-monophosphate accumulation and insulin release in isolated pancreatic islets of the rat. J Biol Chem 249:4196-4201
7. Nesher R, Abramovitch E, Cerasi E 1989 Reduced early and late phase insulin response to glucose in isolated spiny mouse (Acomys cahirinus) islets: a defective link between glycolysis and adenylate cyclase. Diabetologia 32:644-648
8. Hatakeyama H, Kishimoto T, Nemoto T, Kasai H, Takahashi N 2006 Rapid glucose sensing by protein kinase A for insulin exocytosis in mouse pancreatic islets. J Physiol 570:271-282
9. Salehi A, Qader SS, Ekblad E, Ekelund M 2004 Defective insulin secretion during total parenteral nutrition in rat and its normalization by pituitary adenylate cyclase-activating polypeptide 27. Regul Pept 119:83-91
10. Serre V, Dolci W, Schaerer E, Scrocchi L, Drucker D, Efrat S, Thorens B 1998 Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3′,5′-monophosphate levels and β-cell glucose competence. Endocrinology 139:4448-4454
11. Leech CA, Castonguay MA, Habener JF 1999 Expression of adenylyl cyclase subtypes in pancreatic β-cells. Biochem Biophys Rese Commun 254:703-706
12. Gao Z, Young RA, Trucco MM, Greene SR, Hewlett EL, Matschinsky FM, Wolf BA 2002 Protein kinase A translocation and insulin secretion in pancreatic β-cells: studies with adenylate cyclase toxin from Bordetella pertussis. Biochem J 368:397-404
13. Beene DL, Scott JD 2007 A-kinase anchoring proteins take shape. Curr Opin Cell Biol 19:192-198
14. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE, Graybiel AM 1998 A family of cAMP-binding proteins that directly activate Rap1. Science 282:2275-2279
15. Kashima Y, Miki T, Shibasaki T, Ozaki N, Miyazaki M, Yano H, Seino S 2001 Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem 276:46046-46053
16. Omori K, Kotera J 2007 Overview of PDEs and their regulation. Circ Res 100:309-327
17. Mehats C, Andersen CB, Filopanti M, Jin SL, Conti M 2002 Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling. Trends Endocrinol Metab 13:29-35
18. Walz HA, Wierup N, Vikman J, Manganiello VC, Degerman E, Eliasson L, Holst LS 2007 β-Cell PDE3B regulates Ca(2+)-stimulated exocytosis of insulin. Cell Signal 19:1505-1513
19. Gadot M, Leibowitz G, Shafrir E, Cerasi E, Gross DJ, Kaiser N 1994 Hyperproinsulinemia and insulin deficiency in the diabetic Psammomas obesus. Endocrinology 135:610-616
20. Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, Maechler P 2004 Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 145:667-678
21. Costes S, Longuet C, Broca C, Faruque O, Hani EH, Bataille D, Dalle S 2004 Cooperative effects between protein kinase A and p44/p42 mitogen-activated protein kinase to promote cAMP-responsive element binding protein activation after β cell stimulation by glucose and its alteration due to glucotoxicity. Ann NY Acad Sci 1030:230-242
22. Granata R, Settanni F, Biancone L, Trovato L, Nano R, Bertuzzi F, Destefanis S, Annunziata M, Martinetti M, Catapano F, Ghe C, Isgaard J, Papotti M, Ghigo E, Muccioli G 2007 Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic β-cells and human islets: involvement of 3′,5′-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-kinase/Akt signaling. Endocrinology 148:512-529
23. Koh G, Suh KS, Chon S, Oh S, Woo JT, Kim SW, Kim JW, Kim YS 2005 Elevated cAMP level attenuates 2-deoxy-d-ribose-induced oxidative damage in pancreatic β-cells. Arch Biochem Biophys 438:70-79
24. Ding WQ, Dong M, Ninova D, Holicky EL, Stegall MD, Miller LJ 2003 Forskolin suppresses insulin gene transcription in islet β-cells through a protein kinase A-independent pathway. Cell Signal 15:27-35
25. Lawrence MC, Bhatt HS, Easom RA 2002 NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. Diabetes 51:691-698
26. Schofl C, Waring M, Bergwitz C, Arseniev L, von zur Muhlen A, Brabant G 2002 Cyclic-adenosine 3′,5′-monophosphate-stimulated c-fos gene transcription involves distinct calcium pathways in single β-cells. Mol Cell Endocrinol 186:121-131
27. Wang R, Li J, Rosenberg L 2001 Factors mediating the transdifferentiation of islets of Langerhans to duct epithelial-like structures. J Endocrinol 171:309-318
28. Arulmozhi DK, Portha B 2006 GLP-1 based therapy for type 2 diabetes. Eur J Pharm Sci 28:96-108
29. Briones M, Bajaj M 2006 Exenatide: a GLP-1 receptor agonist as novel therapy for type 2 diabetes mellitus. Expert Opin Pharmacother 7:1055-1064
30. Choukem SP, Gautier JF 2006 How do different GLP-1 mimetics differ in their actions? Curr Diab Rep 6:365-372
31. Combettes MM 2006 GLP-1 and type 2 diabetes: physiology and new clinical advances. Curr Opin Pharmacol 6:598-605
32. Levy JC 2006 Therapeutic intervention in the GLP-1 pathway in type 2 diabetes. Diabet Med 23(Suppl 1):14-19
33. Vilsboll T 2007 Liraglutide: a once-daily GLP-1 analogue for the treatment of type 2 diabetes mellitus. Expert Opin Investig Drugs 16:231-237
34. Harndahl L, Wierup N, Enerback S, Mulder H, Manganiello VC, Sundler F, Degerman E, Ahren B, Holst LS 2004 β-Cell-targeted overexpression of phosphodiesterase 3B in mice causes impaired insulin secretion, glucose intolerance, and deranged islet morphology. J Biol Chem 279:15214-15222
35. Walz HA, Harndahl L, Wierup N, Zmuda-Trzebiatowska E, Svennelid F, Manganiello VC, Ploug T, Sundler F, Degerman E, Ahren B, Holst LS 2006 Early and rapid development of insulin resistance, islet dysfunction and glucose intolerance after high-fat feeding in mice overexpressing phosphodiesterase 3B. J Endocrinol 189:629-641
36. Han P, Werber J, Surana M, Fleischer N, Michaeli T 1999 The calcium/ calmodulin-dependent phosphodiesterase PDE1C down-regulates glucose-induced insulin secretion. J Biol Chem 274:22337-22344
37. Hayashi M, Matsushima K, Ohashi H, Tsunoda H, Murase S, Kawarada Y, Tanaka T 1998 Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3′,5′-cyclic nucleotide phosphodiesterase. Biochem Biophys Res Commun 250:751-756
38. Kobayashi T, Gamanuma M, Sasaki T, Yamashita Y, Yuasa K, Kotera J, Omori K 2003 Molecular comparison of rat cyclic nucleotide phosphodiesterase 8 family: unique expression of PDE8B in rat brain. Gene 319:21-31
39. Soderling SH, Bayuga SJ, Beavo JA 1998 Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. Proc Natl Acad Sci USA 95:8991-8996
40. Soderling SH, Bayuga SJ, Beavo JA 1998 Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases. J Biol Chem 273:15553-15558
41. Vasta V, Shimizu-Albergine M, Beavo JA 2006 Modulation of Leydig cell function by cyclic nucleotide phosphodiesterase 8A. Proc Natl Acad Sci USA 103:19925-19930
42. Li L, El-Kholy W, Rhodes CJ, Brubaker PL 2005 Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B. Diabetologia 48:1339-1349
43. Cooper DM 2005 Compartmentalization of adenylate cyclase and cAMP signalling. Biochem Soc Trans 33:1319-1322
44. Tian Y, Laychock SG 2001 Protein kinase C and calcium regulation of adenylyl cyclase in isolated rat pancreatic islets. Diabetes 50:2505-2513
45. Doyle ME, Egan JM 2003 Pharmacological agents that directly modulate insulin secretion. Pharmacol Rev 55:105-131
46. McConnachie G, Langeberg LK, Scott JD 2006 AKAP signaling complexes: getting to the heart of the matter. Trends Mol Med 12:317-323
47. Wong W, Scott JD 2004 AKAP signalling complexes: focal points in space and time. Nature Rev 5:959-970